Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Osimertinib is a third-generation tyrosine kinase inhibitor (TKI) designed for non-small cell lung cancer. Its core synthesis involves complex heterocyclic coupling with high purity standards. Molecular formula: C29H33N7O3; CAS No: 1460958-94-2.
Application
- Oncology Manufacturing: API production for EGFR T790M mutation targeting.
- Pharmaceutical Formulation: Active ingredient in tablet formulations for metastatic NSCLC.
- R&D Laboratories: Standard reagent for resistance mechanism studies.
Precautions
Strictly store below 25°C in moisture-proof containers. Handling requires PPE to avoid inhalation or skin contact due to potential toxicity and mutagenicity risks during manufacturing.